Growth Trends in the Insulin Biosimilar Market, Forecast to 2034
December 05, 2024 10:28 ET
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Insulin Biosimilar Market by Type of Insulin, by Mode of Administration, by Therapeutic Application, by Distribution Channel, and by Region" report has...
Diabetes Pipeline Landscape Research Report 2024: Comprehensive Insights About 200+ Companies and 200+ Pipeline Drugs
November 21, 2024 04:09 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Diabetes - Pipeline Insight, 2024" report...
Rapid-Acting Insulin Market Expected to Reach $11.17 billion by 2032 | 2024 Research Report
September 09, 2024 09:22 ET
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company Analysis 2024-2032" report has been...
Global Insulin Pen Market Report 2024: Data from 2020-2022, Estimates for 2023 and Compound Annual Growth Rates Projections through 2028
February 22, 2024 11:17 ET
|
Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Pen Market" report has been added to ResearchAndMarkets.com's offering. The global insulin pen market was valued at $9.9 billion in...
RYZODEG Drug & Market Forecast Report 2023-2032: Reveals Comprehensive Insights for Type 1 Diabetes Mellitus Treatment - Mechanism of Action, Clinical Assessments, Market Dynamics, Emerging Competitors
January 30, 2024 06:58 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "RYZODEG Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Offering an in-depth analysis of the...